View in EDS HTML Full Text PDF Full Text

Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study.

Saved in:
Bibliographic Details
Title: Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study.
Authors: de Bruijn A; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands., Schipper RJ; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands., Voogd AC; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 LC Utrecht, The Netherlands.; Maastricht University Medical Center, GROW-School for Oncology and Developmental Biology, 6229 HX Maastricht, The Netherlands., Pullens MJJ; Master Advanced Nursing Practice, Faculty of People and Health, Fontys University of Applied Sciences, 5022 DM Tilburg, The Netherlands., Bloemen JG; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands., de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 LC Utrecht, The Netherlands., van Riet YE; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 LC Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, 7522 NB Enschede, The Netherlands., Vriens BEP; Department of Internal Medicine, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands., Nieuwenhuijzen GAP; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.
Source: Cancers [Cancers (Basel)] 2024 Dec 16; Vol. 16 (24). Date of Electronic Publication: 2024 Dec 16.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39766087
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22de+Bruijn+A%22">de Bruijn A</searchLink>; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Schipper+RJ%22">Schipper RJ</searchLink>; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Voogd+AC%22">Voogd AC</searchLink>; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 LC Utrecht, The Netherlands.; Maastricht University Medical Center, GROW-School for Oncology and Developmental Biology, 6229 HX Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Pullens+MJJ%22">Pullens MJJ</searchLink>; Master Advanced Nursing Practice, Faculty of People and Health, Fontys University of Applied Sciences, 5022 DM Tilburg, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bloemen+JG%22">Bloemen JG</searchLink>; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Munck+L%22">de Munck L</searchLink>; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 LC Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Riet+YE%22">van Riet YE</searchLink>; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Siesling+S%22">Siesling S</searchLink>; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 LC Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, 7522 NB Enschede, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vriens+BEP%22">Vriens BEP</searchLink>; Department of Internal Medicine, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Nieuwenhuijzen+GAP%22">Nieuwenhuijzen GAP</searchLink>; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2024 Dec 16; Vol. 16 (24). <i>Date of Electronic Publication: </i>2024 Dec 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39766087
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers16244188
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: de Bruijn A
      – PersonEntity:
          Name:
            NameFull: Schipper RJ
      – PersonEntity:
          Name:
            NameFull: Voogd AC
      – PersonEntity:
          Name:
            NameFull: Pullens MJJ
      – PersonEntity:
          Name:
            NameFull: Bloemen JG
      – PersonEntity:
          Name:
            NameFull: de Munck L
      – PersonEntity:
          Name:
            NameFull: van Riet YE
      – PersonEntity:
          Name:
            NameFull: Siesling S
      – PersonEntity:
          Name:
            NameFull: Vriens BEP
      – PersonEntity:
          Name:
            NameFull: Nieuwenhuijzen GAP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 12
              Text: 2024 Dec 16
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 24
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1